Novo Nordisk's Wegovy obesity drug reduces heart attack and stroke risk by 20%
.thumb.png.ea12d62fcb43a79b1d7a7a4664107cbc.png)
Entry posted by ADMIN
56 views
The study revealed that Wegovy led to a significant 20% reduction in risk of heart attacks and strokes in individuals
0
0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.